Pharmaceutical patents | Intellepedia

Aktiengesellschaft Vormals Meister Lucius & Bruning a Corporation etc.Vs Unichem Laboratories

This post provides a detailed analysis of the Tolbutamide patent infringement case between Aktiengesellschaft Vormals Meister Lucius & Bruning and Unichem Laboratories. It discusses the Court’s interpretation of patent claims and the implications for Indian pharmaceutical patent litigation.

Collar patents for snakes, Foldable iPhone Patent, SIPP Stakeholders meeting, USPTO hikes fees, MSF v. Pfizer, Pneumonia vaccine patent, Roche V Pfizer, Microsoft patent infringement, Patent opposition in India, Patent Tip of the Week and other Weekly Patent News

This week’s patent news highlights notable patent filings, litigations, and policy updates in India. Key stories include MSF’s challenge to Pfizer’s pneumonia vaccine patent, Apple’s foldable iPhone application, and USPTO’s fee hike. The post also reviews patent opposition mechanisms and recent Indian Patent Office statistics.

Military patents, Iron man suit, Glove patents, Unique seminar on patents, MSF vs Pfizer, Dr. Reddy’s patents, Nintendo vs. iLife, Hytera vs. Motorola, Innovation patents, Portfolio Pruning, Patent Tip of the Week and more.

This update covers major Indian and international patent news, including litigation, innovation, and key statistics. Highlights include the Iron Man suit invention, glove patents, pharmaceutical litigation, and patent seminars. The post also offers practical guidance on patent portfolio management.

Delhi High Court, Upcoming events, Xiaomi patents and more.

This update examines patent infringement rulings by the Delhi High Court, statistics from the Indian Patent Office, international patent acquisitions, and licensing settlements. It also features expert analysis and practical guidance for patent applicants.

Apple sues Qualcomm again, Major Setback to Bayer, Delhi HC allows export of patented drug and much more.

This update highlights key events in intellectual property law, including Apple’s lawsuit against Qualcomm and Bayer’s loss in the Delhi High Court. Further, it discusses recent trademark and patent disputes as well as upcoming conferences, offering an objective legal perspective.

UNDP Issues Guidelines For Pharmaceutical Patent Examination

The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of TRIPS flexibilities to curb evergreening and improve access to medicines.

Lee and BDR decision – the End of Compulsory Licenses?!

The Lee and BDR decisions signal a shift in the landscape of compulsory licensing in India. This post examines the legal and policy developments leading to these outcomes, highlighting their implications for the Indian pharmaceutical industry.

Government Bats for US trained Patent Examiners

The Indian government’s plan to engage US trained patent examiners has sparked debate over efficiency and policy direction in the patent office. This post analyses the benefits, concerns, and broader implications for India’s patent examination system.

Merck v. Glenmark – A Bitter Battle of Pills

The Delhi High Court restrained Glenmark from manufacturing and marketing generic versions of Merck’s patented antidiabetic drugs. This case underscores key principles of Indian patent law and the balance between patent rights and public interest.

Compulsory Licensing in India

This article analyses the evolution and practice of compulsory licensing in India, focusing on landmark cases and their effects on patent activity. It assesses whether compulsory licensing influences innovation and discusses the operational challenges within the Indian Patent Office.